全文获取类型
收费全文 | 39152篇 |
免费 | 3278篇 |
国内免费 | 2166篇 |
专业分类
耳鼻咽喉 | 519篇 |
儿科学 | 758篇 |
妇产科学 | 630篇 |
基础医学 | 4447篇 |
口腔科学 | 872篇 |
临床医学 | 4730篇 |
内科学 | 5879篇 |
皮肤病学 | 540篇 |
神经病学 | 2145篇 |
特种医学 | 1993篇 |
外国民族医学 | 12篇 |
外科学 | 5294篇 |
综合类 | 4906篇 |
现状与发展 | 6篇 |
一般理论 | 7篇 |
预防医学 | 2502篇 |
眼科学 | 939篇 |
药学 | 3674篇 |
28篇 | |
中国医学 | 1631篇 |
肿瘤学 | 3084篇 |
出版年
2024年 | 85篇 |
2023年 | 496篇 |
2022年 | 1233篇 |
2021年 | 1636篇 |
2020年 | 1211篇 |
2019年 | 1174篇 |
2018年 | 1257篇 |
2017年 | 1160篇 |
2016年 | 1265篇 |
2015年 | 1689篇 |
2014年 | 1973篇 |
2013年 | 1921篇 |
2012年 | 2434篇 |
2011年 | 2760篇 |
2010年 | 1841篇 |
2009年 | 1454篇 |
2008年 | 1866篇 |
2007年 | 1983篇 |
2006年 | 1870篇 |
2005年 | 1826篇 |
2004年 | 1474篇 |
2003年 | 1394篇 |
2002年 | 1307篇 |
2001年 | 1104篇 |
2000年 | 1034篇 |
1999年 | 1018篇 |
1998年 | 582篇 |
1997年 | 628篇 |
1996年 | 434篇 |
1995年 | 370篇 |
1994年 | 294篇 |
1993年 | 258篇 |
1992年 | 329篇 |
1991年 | 316篇 |
1990年 | 263篇 |
1989年 | 265篇 |
1988年 | 211篇 |
1987年 | 201篇 |
1986年 | 189篇 |
1985年 | 143篇 |
1984年 | 104篇 |
1983年 | 90篇 |
1982年 | 58篇 |
1981年 | 70篇 |
1980年 | 56篇 |
1979年 | 89篇 |
1978年 | 60篇 |
1975年 | 61篇 |
1974年 | 61篇 |
1973年 | 63篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Michels Guido Horn Rudolf Helfen Andreas Hagendorff Andreas Jung Christian Hoffmann Beatrice Jaspers Natalie Kinkel Horst Greim Clemens-Alexander Knebel Fabian Bauersachs Johann Busch Hans-Jörg Kiefl Daniel Spiel Alexander O. Marx Gernot Dietrich Christoph F. 《Der Anaesthesist》2022,71(4):307-310
Die Anaesthesiologie - 相似文献
2.
3.
Xiumei Jiang Xiaowei Zhang Patrick Gray Jiwen Zheng Timothy R. Croley Peter P. Fu 《journal of environmental science and health part c-environmental carcinogenesis & ecotoxicology reviews》2019,37(2):116-131
Gold nanoparticles (Au NPs) hold great promise in food, industrial and biomedical applications due to their unique physicochemical properties. However, influences of the gastrointestinal tract (GIT), a likely route for Au NPs administration, on the physicochemical properties of Au NPs has been rarely evaluated. Here, we investigated the influence of GIT fluids on the physicochemical properties of Au NPs (5, 50, and 100?nm) and their implications on intestinal epithelial permeability in vitro. Au NPs aggregated in fasted gastric fluids and generated hydroxyl radicals in the presence of H2O2. Cell studies showed that GIT fluids incubation of Au NPs affected the cellular uptake of Au NPs but did not induce cytotoxicity or disturb the intestinal epithelial permeability. 相似文献
4.
Esin Benli Küçük Ercan Kaydok Kürsad Ramazan Zor Gamze Yıldırım Biçer 《Topics in stroke rehabilitation》2020,27(8):630-635
ABSTRACT Objective: Dry eye is reported to be associated with several neurological diseases. The aim of this study is to evaluate the patients with hemiplegia after stroke for dry eye and compare their results with a control group. Materials and methods: Forty-five patients with hemiplegia and 45 individuals as the control group were included in the study. Tear function tests (Schirmer and tear breakup time) and a dry eye questionnaire for dry eye symptoms (ocular surface disease index) were performed and the results of the two groups were compared. Results: Schirmer test results were significantly lower in the post-stroke hemiplegia group compared to the control group (11.3 ± 8.2 mm and 20.6 ± 11.6 mm, respectively, p < .001). Tear breakup time results were significantly lower in the post-stroke hemiplegia group compared to the control group (7.9 ± 3.1 s and 12.1 ± 4.3 s, respectively, p < .001). Ocular surface disease index scores were not significantly different between hemiplegia and control groups (21.6 ± 20.0 and 19.8 ± 13.9, respectively, p = .635). Schirmer scores lower than 10 mm (60% and 30%, p < .001) and tear breakup time results lower than 10 s (65.6% and 28.9%, p < .001) were also higher in the hemiplegia group compared to control group. Conclusion: We found lower Schirmer test and tear breakup time results and similar OSDI scores in hemiplegia patients compared to controls. Hemiplegia patients may have dry eye without typical symptoms. This should be taken into consideration in the follow-up and rehabilitation of post-stroke hemiplegia patients. 相似文献
5.
6.
7.
Simeprevir added to peginterferon and ribavirin lessens time with fatigue,depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST‐1, QUEST‐2 and PROMISE studies
下载免费PDF全文
![点击此处可从《Journal of viral hepatitis》网站下载免费的PDF全文](/ch/ext_images/free.gif)
J. Scott L. Gilles M. Fu E. Brohan C. Panter R. Arbuckle W. Jessner M. Beumont 《Journal of viral hepatitis》2015,22(8):639-650
The value of adding simeprevir (SMV) vs placebo (PBO) to peginterferon and ribavirin (PR) for treatment of chronic hepatitis C virus infection was examined using patient‐reported outcomes (PROs); further, concordance of PROs with virology endpoints and adverse events (AEs) was explored. Patients (n = 768 SMV/PR, n = 393 PBO/PR) rated fatigue (FSS), depressive symptoms (CES‐D) and functional impairment (WPAI: Hepatitis C Productivity, Daily Activity and Absenteeism) at baseline and throughout treatment in three randomised, double‐blind trials comparing the addition of SMV or PBO during initial 12 weeks of PR. PR was administered for 48 weeks (PBO group) and 24/48 weeks (SMV group) using a response‐guided therapy (RGT) approach. Mean PRO scores (except Absenteeism) worsened from baseline to Week 4 to the same extent in both groups but reverted after Week 24 for SMV/PR and only after Week 48 for PBO/PR. Accordingly, there was a significantly lower area under the curve (baseline–Week 60, AUC60) and fewer weeks with clinically important worsening of scores in the SMV/PR group at any time point. Incidences of patients with fatigue and anaemia AEs were similar in both groups, but FSS scores showed that clinically important increases in fatigue lasted a mean of 6.9 weeks longer with PBO/PR (P < 0.001). PRO score subgroup analysis indicated better outcomes for patients who met the criteria for RGT or achieved sustained virological response 12 weeks post‐treatment (SVR12); differences in mean PRO scores associated with fibrosis level were only observed with PBO/PR. Greater efficacy of SMV/PR enabled reduced treatment duration and reduced time with PR‐related AEs without adding to AE severity. 相似文献
8.
9.
10.